These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20443242)

  • 1. [Omaron in the restorative treatment of patients with chronic cerebrovascular insufficiency].
    Stroganova IM; Kiparisov MA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):70-2. PubMed ID: 20443242
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phezam in combined therapy of ischemic stroke].
    Arabkhanova MA; Pyshkina LI; Kabanov AA; Kolesnikova TI; Iasamanova AN; Martynov MIu; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):24-6. PubMed ID: 18646379
    [No Abstract]   [Full Text] [Related]  

  • 3. [Omaron in the treatment of vertebrobasilar insufficiency].
    Lobzin SV; Bodrova TV; Vasilenko AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(1):40-3. PubMed ID: 19156085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Omaron in the rehabilitation of post stroke outpatients].
    Chuprina SE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(6):54-7. PubMed ID: 20559275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of omaron in patients with post-stroke cognitive disorders].
    Parfenov VA; Belavina GR; Vakhnina NV; Gusev VV; Levin IaI; Markin SP; Starchina IuA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(6):41-5. PubMed ID: 19672226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phezam efficacy in patients with chronic cerebral ischemic disease].
    Boĭko AN; Kabanov AA; Es'kina TA; Sheliakina LA; Shchukin AI; Batysheva TT; Artemova IIu; Vdovichenko TV; Volovets SA; Ganzhula PA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):36-41. PubMed ID: 15704481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacotherapy of endothelial dysfunction in patients with atherosclerotic brain ischemia].
    Fedin AI; Starykh EP; Parfenov AS; Mironova OP; Abdrakhmanova EK; Starykh EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(10):45-8. PubMed ID: 24300805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of the neuroprotective activity of phenotropil and piracetam in laboratory animals with experimental cerebral ischemia].
    Tiurenkov IN; Bagmetov MN; Epishina VV
    Eksp Klin Farmakol; 2007; 70(2):24-9. PubMed ID: 17523446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vinpotropile in the treatment of cerebral vascular diseases].
    Filimonov VA; Kliueva VN; Kondrasheva IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):58-60. PubMed ID: 18689000
    [No Abstract]   [Full Text] [Related]  

  • 10. [The influence of cinnarizine and alvityl on cerebral blood flow and high nervous activity in chronic cerebral ischemia model].
    Gromova OA; Grishina TR; Sadin AV; Nikonov AA; Nazarenko OA; Zhidomorov NIu; Vatsuro AA; Borzunov MP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):52-3. PubMed ID: 14870694
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute disorders of cerebral circulation in arteriosclerotic dyscirculatory encephalopathy].
    Ravelin EE; Makarova LD
    Sov Med; 1991; (9):53-5. PubMed ID: 1798925
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy in the early stage of cerebral insufficiency. Clinical and technical possibilities for evaluating the vascular system].
    Fortschr Med Suppl; 1986; 1():9-10. PubMed ID: 2868982
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of the therapeutic effectiveness of drugs of different mechanisms of action in cerebral atherosclerosis].
    Sobczyk W
    Neurol Neurochir Pol; 1982; 16(4):245-60. PubMed ID: 7145012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulatory effect of kallikrein; with special reference to cerebral circulation.
    Miyazaki M
    Adv Exp Med Biol; 1989; 247B():607-10. PubMed ID: 2610098
    [No Abstract]   [Full Text] [Related]  

  • 15. [Omaron in the complex treatment of patients with multiple sclerosis].
    Popova NF; Kamchatnov PR; Riabukhina OV; Batysheva TT; Zaĭtsev KA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 1):17-20. PubMed ID: 21183917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical cerebrovascular disease in older adults.
    Hadjiev DI; Mineva PP
    Stroke; 2010 Jun; 41(6):e447; author reply e448-9. PubMed ID: 20431076
    [No Abstract]   [Full Text] [Related]  

  • 17. [Piracetam and tocopherol acetate ability to potentiate clinical effect of antianginal drugs in presenile and senile patients with ischemic heart disease (unstable angina)].
    Pimenov LT; Churshin AD; Ezhov AV
    Klin Med (Mosk); 1997; 75(1):32-5. PubMed ID: 9082055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood flow volume quantification of cerebral ischemia: comparison of three noninvasive imaging techniques of carotid and vertebral arteries.
    Ho SS; Chan YL; Yeung DK; Metreweli C
    AJR Am J Roentgenol; 2002 Mar; 178(3):551-6. PubMed ID: 11856672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Piracetam and the indicators of cerebral hemodynamics, lipid metabolism and rheological properties of blood in the initial forms of cerebrovascular disorders].
    Eninia GI; Timofeeva TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(11):20-3. PubMed ID: 1963971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of sermion in cerebral atherosclerosis patients with a history of ischemic stroke].
    Tsimenko OA; Sosnov IuD; Kharchenko AP; Gaĭduk IuS
    Vrach Delo; 1988 Jul; (7):24-7. PubMed ID: 3188456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.